These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3324261)

  • 21. Biotechnological Production of Anti-cancer Compounds.
    Malik S
    Curr Med Chem; 2018; 25(36):4654-4655. PubMed ID: 30563439
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy with lymphokine combinations.
    Mulé JJ; Rosenberg SA
    Important Adv Oncol; 1989; ():99-126. PubMed ID: 2468602
    [No Abstract]   [Full Text] [Related]  

  • 23. Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
    Cerny N; Sánchez Alberti A; Bivona AE; De Marzi MC; Frank FM; Cazorla SI; Malchiodi EL
    Hum Vaccin Immunother; 2016; 12(2):438-50. PubMed ID: 26312947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.
    Terranova-Barberio M; Thomas S; Munster PN
    Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The interplay of immunotherapy and chemotherapy, a novel approach].
    Hanoteau A; Henin C; Moser M
    Med Sci (Paris); 2016 Apr; 32(4):353-61. PubMed ID: 27137692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological research and cancer: A call to arms.
    Smalley KSM
    Pharmacol Res; 2019 Aug; 146():104291. PubMed ID: 31158465
    [No Abstract]   [Full Text] [Related]  

  • 27. Are there, or shall we discover, biomarkers to guide PD-1 inhibition?
    Ascierto PA; de Mello RA
    Immunotherapy; 2016 Jun; 8(6):681-6. PubMed ID: 27197537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stocking oncology's medicine cabinet.
    Kiberstis PA; Travis J
    Science; 2017 Mar; 355(6330):1142-1143. PubMed ID: 28302820
    [No Abstract]   [Full Text] [Related]  

  • 29. Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.
    Stevenson HC; Klein HG
    Prog Clin Biol Res; 1990; 337():559-65. PubMed ID: 2353018
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy and chemotherapy for carcinoma of the kidney.
    Ramsay J
    Br J Urol; 1992 Nov; 70(5):465-8. PubMed ID: 1467846
    [No Abstract]   [Full Text] [Related]  

  • 31. New response criteria proposed for immunotherapies.
    Tuma RS
    J Natl Cancer Inst; 2008 Sep; 100(18):1280-1. PubMed ID: 18780859
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy and immunotherapy of cancer. Current advances].
    Amiel JL
    Sem Hop Ther; 1977 Nov; 53(9):473-4. PubMed ID: 601567
    [No Abstract]   [Full Text] [Related]  

  • 33. Human Vaccines & Immunotherapeutics: News.
    Hum Vaccin Immunother; 2017 Feb; 13(2):251-252. PubMed ID: 28215123
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunotherapy of hepatocellular carcinoma].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1464-6. PubMed ID: 11753738
    [No Abstract]   [Full Text] [Related]  

  • 35. Next steps for cancer immune therapy.
    Cancer Discov; 2015 Mar; 5(3):221-2. PubMed ID: 25710919
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemo- and immunotherapy of malignant neoplasms].
    Matthias M
    Z Arztl Fortbild (Jena); 1975 Jun; 69(11):580-4. PubMed ID: 1065149
    [No Abstract]   [Full Text] [Related]  

  • 37. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasite-induced chronic inflammation is not exacerbated by immunotherapy before or during Trypanosoma cruzi Infection.
    Duthie MS; Kahn M; Zakayan A; White M; Kahn SJ
    Clin Vaccine Immunol; 2007 Aug; 14(8):1005-12. PubMed ID: 17538117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemo- and immunotherapy of colorectal cancer].
    Klein HO
    Internist (Berl); 1991 Jun; 32(6):348-53. PubMed ID: 1880013
    [No Abstract]   [Full Text] [Related]  

  • 40. Bispecific antibodies for cancer therapy.
    Chames P; Baty D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.